Description:PF-4136309, identified by its CAS number 1341224-83-6, is a small molecule that has been investigated primarily for its potential therapeutic applications, particularly in the context of cancer treatment. It functions as a selective inhibitor of certain kinases, which are enzymes that play crucial roles in various cellular processes, including cell growth and division. The compound's mechanism of action typically involves the modulation of signaling pathways that are often dysregulated in cancer cells. In terms of its physical and chemical properties, PF-4136309 is characterized by its specific molecular structure, which includes functional groups that contribute to its biological activity and solubility. The compound's efficacy and safety profile are evaluated through preclinical and clinical studies, focusing on its ability to inhibit tumor growth and its potential side effects. As with many investigational drugs, ongoing research aims to better understand its pharmacokinetics, pharmacodynamics, and overall therapeutic potential in oncology.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
![N-[2-[(3S)-3-[[4-Hydroxy-4-[5-(pyrimidin-2-yl)pyridin-2-yl]cyclohexyl]amino]pyrrolidin-1-yl]-2-oxo…](https://static.cymitquimica.com/products/IN/thumb/DA00392L.jpg)
